Opportunity Information: Apply for PAR 23 122
The NIH Research With Activities Related to Diversity (ReWARD) Program is an R01 funding opportunity (clinical trial optional) designed to broaden who NIH funds and where NIH-supported research happens. The central idea is to expand the breadth and geographic distribution of NIH-backed research by supporting investigators who are actively contributing to Diversity, Equity, Inclusion, and Accessibility (DEIA) and who currently do not hold NIH Research Project Grant (RPG) funding. In practice, this means the program is aimed at researchers who are already doing meaningful DEIA work and are ready to pair that work with a strong, NIH-aligned health research project, but who have not yet secured (or do not currently have) NIH RPG support.
A defining feature of ReWARD is that it funds two connected components under one award: (1) a health-related scientific research project that aligns with the mission and program interests of one or more participating NIH Institutes and Centers (ICs), and (2) the applicant investigator's ongoing DEIA activities that help strengthen diversity within the U.S. biomedical research enterprise. Rather than treating DEIA efforts as an afterthought, the program explicitly supports them alongside the research itself, recognizing that building a more inclusive research workforce and pipeline is part of the overall impact NIH is trying to achieve. The DEIA activities are expected to be real, sustained efforts (not just one-time outreach) and focused on enhancing diversity in biomedical research across the United States and U.S. territories.
The opportunity is issued by the National Institutes of Health (NIH) and is listed as Funding Opportunity Number PAR-23-122. It is a discretionary grant program and falls under the broad activity areas of education and health. Multiple CFDA numbers are associated with it (including 93.121, 93.172, 93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.307, 93.310, 93.313, 93.846, 93.859, 93.867, 93.879), reflecting that multiple NIH components may participate and that awards can span a wide range of biomedical and behavioral research domains depending on institute priorities.
Eligibility is broad and includes many typical NIH applicant organization types. Eligible applicants include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; nonprofit organizations with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; small businesses; and other organizations as allowed under NIH policy. The announcement also highlights additional eligible applicant categories that align with the program's emphasis on diversifying the research ecosystem, such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), as well as faith-based or community-based organizations, regional organizations, eligible federal agencies, Indian/Native American Tribal Governments (other than federally recognized), and U.S. territories or possessions.
There are important limits related to foreign participation. Non-domestic (non-U.S.) entities (foreign organizations and foreign institutions) are not eligible to apply as the applicant organization. Non-domestic components of U.S. organizations are also not eligible to apply. However, foreign components, as NIH defines them in the NIH Grants Policy Statement, are allowed. In other words, the application must be led by an eligible domestic applicant organization, but the project can include certain foreign components when justified and compliant with NIH policy.
The posted original closing date is 2026-05-07, and the funding opportunity was created on 2023-03-16. The award ceiling and expected number of awards are not specified in the provided source data, which is common for some NIH FOAs where budgets and award counts depend on available appropriations, institute participation, and the merit of applications received. Overall, ReWARD is best understood as an NIH R01 mechanism that intentionally ties strong, fundable health research to credible, ongoing DEIA contributions, with the goal of expanding access to NIH funding and strengthening the diversity and reach of the biomedical research enterprise across the U.S. and its territories.Apply for PAR 23 122
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.121, 93.172, 93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.307, 93.310, 93.313, 93.846, 93.859, 93.867, 93.879.
- This funding opportunity was created on 2023-03-16.
- Applicants must submit their applications by 2026-05-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Education, Health
Next opportunity: Emergency Award: Novel Insights through Cross-Site Analyses of Existing RADx-UP Data (R21 Clinical Trial Not Allowed)
Previous opportunity: NIJ FY23 Research and Evaluation of Services for Victims of Crime
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 23 122
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 23 122) also looked into and applied for these:
| Funding Opportunity |
|---|
| NIDA Avant-Garde Program for HIV and Substance Use Disorder Research (DP1 Clinical Trial Optional) Apply for PAR 23 269 Funding Number: PAR 23 269 Agency: National Institutes of Health Category: Education, Health Funding Amount: $700,000 |
| Discovery and Development of Natural Products for Cancer Interception and Prevention (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA CA 23 028 Funding Number: RFA CA 23 028 Agency: National Institutes of Health Category: Education, Health Funding Amount: $250,000 |
| Impacts of climate change across the cancer control continuum (R01 Clinical Trial Optional) Apply for PAR 23 153 Funding Number: PAR 23 153 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Impacts of climate change across the cancer control continuum (R21 Clinical Trial Optional) Apply for PAR 23 152 Funding Number: PAR 23 152 Agency: National Institutes of Health Category: Education, Health Funding Amount: $275,000 |
| Request for Applications (RFA): Revision Applications to Support Research on Prevention and Cessation of Menthol Cigarette Use in Populations that Experience Health Disparities (R01, Clinical Trial Optional) Apply for RFA OD 23 015 Funding Number: RFA OD 23 015 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Liver Cancer Collaborative Projects with the Liver Cirrhosis Network (U01 Clinical Trial Optional) Apply for RFA CA 23 023 Funding Number: RFA CA 23 023 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Implementation Science for Cancer Control in People Living with HIV in Low- and Middle-Income Countries (U01 Clinical Trial Optional) Apply for RFA CA 23 033 Funding Number: RFA CA 23 033 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Understanding Persistent Oral Human Papillomavirus and Human Immunodeficiency Virus Co-infection and Its Role with Oropharyngeal Cancer Induction (R01 Clinical Trial Not Allowed) Apply for RFA DE 24 001 Funding Number: RFA DE 24 001 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans (BESH) Required) Apply for PAR 23 158 Funding Number: PAR 23 158 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional) Apply for PAR 23 157 Funding Number: PAR 23 157 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required) Apply for PAR 23 155 Funding Number: PAR 23 155 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Mechanistic Studies to Investigate the Interrelationship Between Sleep and/or Circadian Rhythms and Substance Use Disorders (R01 Clinical Trials Not Allowed) Apply for RFA DA 24 020 Funding Number: RFA DA 24 020 Agency: National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R41/R42 Clinical Trial Optional) Apply for RFA DA 24 038 Funding Number: RFA DA 24 038 Agency: National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Mechanistic Studies to Investigate the Interrelationship Between Sleep and/or Circadian Rhythms and Substance Use Disorders (R01 Basic Experimental Studies with Humans Required) Apply for RFA DA 24 021 Funding Number: RFA DA 24 021 Agency: National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required) Apply for PAR 23 170 Funding Number: PAR 23 170 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Ending the HIV Epidemic: Resource Center to Engage Justice-Involved Populations (U24 Clinical Trial Optional) Apply for RFA DA 24 022 Funding Number: RFA DA 24 022 Agency: National Institutes of Health Category: Education, Health Funding Amount: $350,000 |
| Ending the HIV Epidemic: Focus on Justice Populations with SUD (R61/R33 Clinical Trial Required) Apply for RFA DA 24 015 Funding Number: RFA DA 24 015 Agency: National Institutes of Health Category: Education, Health Funding Amount: $750,000 |
| Ending the HIV Epidemic: Focus on Justice Populations with SUD-Data Coordination and Dissemination Center (UM1 Clinical Trial Optional) Apply for RFA DA 24 023 Funding Number: RFA DA 24 023 Agency: National Institutes of Health Category: Education, Health Funding Amount: $1,000,000 |
| Cancer Immunoprevention Network (CIP-Net) ?Research Projects (UG3/UH3 Clinical Trials Not Allowed) Apply for RFA CA 23 029 Funding Number: RFA CA 23 029 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional) Apply for RFA CA 24 005 Funding Number: RFA CA 24 005 Agency: National Institutes of Health Category: Education, Health Funding Amount: $475,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 23 122", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.